Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas

American Journal of Neuroradiology

Volumn 21, Issue 4, 2000, Pages 659-665

  Shimizu, Hiroaki ^a   Kumabe, Toshihiro ^b   Shirane, Reizo ^b   Yoshimoto, Takashi ^b  

^a KOHNAN HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; ASTROCYTOMA; BRAIN LEVEL; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; NEUROPATHOLOGY; OLIGODENDROGLIOMA; PREDICTION; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ASSAY;

ADULT; AGED; BRAIN NEOPLASMS; CELL DIVISION; CHOLINE; FEMALE; GLIOMA; HUMANS; KI-67 ANTIGEN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 0034118137     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Heiss WD, Heindel W, Herholz K, et al. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors. J Nucl Med 1990;31:302-310
2. Herholz K, Heindel W, Luyten PR, et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 1992;31:319-327
3. 18F-fluoro-2′-deoxyuridine and brain tumor: a new approach to nucleic acid metabolism by ARG and PET. J Cereb Blood Flow Metab 1987; 7:459-464
4. Kameyama M, Tsurumi Y, Shirane R, et al. Multi-parametric analysis of brain tumor with PET. J Cereb Blood Flow Metab 1987;7:466-470
5. Black LK, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989;71:342-346
6. Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990;31:965-969
7. Louis DN, Edgerton S, Thor AD, Hedley-Whyte ET. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol (Berl) 1991;81: 675-679
8. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 1994;74:1921-1926
9. Steck K, El-Naggar AK. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Cytometry 1994;17:258-265
10. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93
11. Barker PB, Glickson JD, Bryan RN. In vivo magnetic resonance spectroscopy of human brain tumors. Top Magn Reson Imaging 1993;5:32-45
12. 1H MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172:541-548
13. 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Compul Assist Tomogr 1991;15:67-76
14. Fulham MJ, Bizz A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686
15. Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497-504
16. 1H-spectroscopy of human intracranial tumors at 1.5 tesla: preliminary experience al a clinical installation. Acta Radiol 1991; 32:95-99
17. 1H MR spectroscopic imaging and PET. Radiology 1990;176:791-799
18. 1H magnetic resonance spectroscopy. Surg Neurol 1995;44:137-144
19. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449-458
20. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752
21. 1H NMR spectroscopy imaging. Magn Reson Med 1990;13:62-76
22. Hagberg G, Burlina AP, Mader I, Roser W, Radue EW, Seelig J. In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification. Magn Reson Med 1995;34:242-252
23. Kugel H, Heindel W, Ernestus R-I, Bunke J, du Mensil R, Friedmann G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-709
24. Sijens PE, van Dijk P, Oudkerk M. Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma. Magn Reson Med 1994;32: 549-555
25. Tien RD, Lai PH, Smith JS, Lazeyras E Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJR Am J Roentgenol 1996;35:201-209
26. Shimizu H, Kumabe T, Tominaga T, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:737-747
27. Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. 2nd ed. Berlin: Springer:1993;11-30
28. Kumahe T, Shimizu H, Sonoda Y, Shirane R, Thallium-201 single-photon emission computed tomographic and proton magnetic resonance spectroscopic characteristics of intracranial ganglioglioma: report of three cases. Neurosurgery 1999;45: 183-187.
29. Shi SR, Key ME, Kalra KL, Antigen retrieval in formalin-fixed paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Hisiochem Cytochem 1991;39:741-748
30. 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. J Neuroimaging 1995;5:157-163
31. 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 1994;18:705-713